Process Analytical Technology: An Industry Perspective John G. Shabushnig, Ph.D. Pharmacia Corporation February 25, 2002.

Slides:



Advertisements
Similar presentations
QAD Item Attributes and Quality Control Forrest Mori – Principal Business Analyst West Coast User Group, February 11, 2013.
Advertisements

Statistical Approaches to Addressing the Requirements of the New FDA Process Validation Guidance for Small Molecules 1 Jason Marlin, MS/T Statistics, Eli.
Finished Pharmaceutical Product Specifications
Sultan Ghani WHO Prequalification Programme of Priority Essential Medicines, October 2010, Abu Dhabi, U.A.E. Experience of Pre-Qualification Program.
Extended Range NIR Wavelength Standard Gabor J. Kemeny, Ph.D. Kemtek Analytical, Inc. PAT Subcommittee February 25th 2002.
Listeria Monitoring & Testing in RTE seafood plants
Manufacturing Process
Rapid Microbiology Methods A Regulatory Viewpoint Bryan S. Riley, Ph.D. U.S. Food and Drug Administration Center for Drug Evaluation and Research Office.
Chemistry, Manufacturing, and Controls (CMC) and Good Manufacturing Practices (GMPs): The Big Picture of a Long-term Commitment Elizabeth Pollina Cormier,
World Health Organization
Determine impurity level in relevant batches1
Quality by Design (QbD) in Product Development
The concept of Quality ● Quality means those features of products which meet customers needs and thereby provide customer satisfaction. This meaning is.
Free Powerpoint Templates Page 1 Mohammad Khalid Anwer, Ph.D - Mohammad Khalid Anwer, Ph.D -
Quality control of raw materials In-process control
QUALITY CONTROL CHAPTER 1 QUALITY CONTROL Roselyn Aperocho-Naranjo, RPh, MPH
Process Analytical Technologies Subcommittee Product and Process Development: An Industry Perspective David Rudd PhD Process Technology GlaxoSmithKline.
An Industry Perspective on the Potential for Emerging Process Analytical Technologies Norman Winskill Steve Hammond Pfizer Global Manufacturing Services.
Ray Scherzer FDA ACPS October 26, 2005 Breaking with Tradition: The Manufacturing Challenges Ahead!
MIT PHARMACEUTICAL MANUFACTURING INITIATIVE (PHARMI) PHARMACEUTICAL MANUFACTURING: NEW TECHNOLOGY OPPORTUNITIES.. G.K.Raju, Ph.D. Executive Director, Pharmaceutical.
Laboratory Information Management Systems (LIMS) Lindy A. Brigham Div of Plant Pathology and Microbiology Department of Plant Sciences PLS 595D Regulatory.
CHEM-3245 Quantitative Analysis
World Health Organization
PAT Validation Working Group Process and Analytical Validation Working Group Arthur H. Kibbe, Ph.D. Chair June 13, 2002.
HIV Testing Quality Assurance and Quality Control
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Learnings from Pre-approval Joint Inspection of a GSK QbD Product with US-FDA & EMA and the application of Continuous Verification 17 May 2011, Beijing,
Xcellerex … speeding medicines to people … PAT for Biologics Ensuring Quality of Biologically Produced Drugs FDA Advisory Committee on Pharmaceutical Sciences.
MANUFACTURING OF PHARMACEUTICALS Chapter 1 Roselyn Aperocho-Naranjo USPF-College of Pharmacy
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
 A central concept is that quality cannot be tested for! ◦ Testing programs are based on testing a statistically significant number of samples  However.
University of Medicine and Pharmacy „Iuliu Haţieganu”, Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, , Cluj-Napoca,
D. Christopher Watts, Ph.D. Office of Pharmaceutical Science, CDER, FDA Science Seminar Series for the Office of Commissioner April 9, 2004 Process Analytical.
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
© NextPharma Technologies 2006 NextPharma Technologies Experts in the production of Pellets.
Introduction to Analytical Chemistry
INTRODUCTION TO ANALYTICAL CHEMISTRY ERT 207 ANALYTICAL CHEMISTRY SEMESTER 1, ACADEMIC SESSION 2015/16.
Applications of Analytical Chemistry in Pharmaceuticals Corey M. Chong 10Mar10.
Module 1, Part 3: Process validation Slide 1 of 22 © WHO – EDM – 12/2001 Validation Part 3: Process validation Supplementary Training Modules on Good Manufacturing.
Blend Uniformity - PQRI Research
1 PAT and Biological Products Tom Layloff FDA-SGE Management Sciences for Health The views expressed here are those of the author and not necessarily.
1-7.The ICH Q8 “Minimal Approach” to Pharmaceutical Development
A Qualitative Decision Making Tool to Aid in Defining the Number of Lots for a Process Validation Campaign Leslie Sidor — Amgen Inc Midwest Biopharmaceutical.
Estimation of Moisture Content in Paper Pulp Containing Calcium Carbonate Using Fringing Field Impedance Spectroscopy Kishore Sundara-Rajan, Leslie Byrd.
Important informations
NeSSI™ - Gen III Finding the Longitude – the microAnalytical Vision Rob Dubois CPAC/NeSSI™ Workshop – PM Session Seattle, Washington, USA May 6, 2004 “the.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
Small molecules Liquids – Solvent composition – Reactions – HME Dry Powder – Blending – Dry Granulation – Dry milling Wet solids – API Crystallization.
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
FDA PROCESS ANALYTICAL TECHNOLOGY SUB COMMITTEE MEETING 25 TH FEBRUARY 2002 PERSPECTIVE ON PROCESS AND ANALYTICAL VALIDATION Robert S Chisholm.
Laboratory of Methods Development and Quality Control Laboratory Overview September 22, 2005.
Stability Trials ASEAN Guidelines. The Objective of a stability study To determine the shelf life, namely the time period of storage at a specified condition.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
Process Understanding and PAT
Why must chemistry students do experimental practical work? To help students learn science – acquire and develop conceptual and theoretical knowledge.
1 PAT Subcommittee Closing Report 12 March 2003 Tom Layloff Acting Chair.
Second Meeting of the FDA/ACPS Process Analytical Technology: Closing Remarks Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Sciences.
FDA’s Advisory Committee for Pharmaceutical Science The Subcommittee on Process Analytical Technologies (PAT): Closing Remarks Ajaz S. Hussain, Ph.D. Deputy.
FDA PAT Sub-Committee of Advisory Committee for Pharmaceutical Sciences June 12-13, 2002; Gaithersburg, MD Regulatory Challenges: Post-Approval PAT Applications.
开发报批美国 FDA 的仿制药 与相关问题探讨 上海复星普适医药科技有限公司何平. 内容提要 开发仿制药的重要性和机遇 开发仿制药的重要性和机遇 开发仿制药的挑战 开发仿制药的挑战 申报仿制药的分类 申报仿制药的分类 仿制药研发团队 仿制药研发团队 仿制药的研发过程 仿制药的研发过程 QbD 在制剂开发中怎么体现.
QbD Technologies: Workshop for Risks Management Incorporating Risk Management for Technology Transfer.
Product & Process Working Group February 26, 2002.
EQUIPMENT and METHOD VALIDATION
FREEZE DRYING OF VACCINES- CURRENT TRENDS AND FUTURE SCOPE
Serial/Fiber-Converter - IE-MCT-1RS232/485-1SC/ST
PROCESS ANALYTICAL TECHNOLOGY – A REVIEW By Mr. Akash Mali DEPARTMENT OF PHARMACEUTICS, G.I.P.E.R., LIMB, SATARA. 1.
Physico-chemical Control of Dosage Forms
Author: Nurul Azyyati Sabri
Lesson 5: BRITE Seminar: GMP II
-·.-...-· A. -.. ) ,.,.. -.,., · o# --·'1>,.. ·-·-. ·-· ;'/' : ,.,. - ' p ·-·- ·-- 'II"; -.-. t-.. p
Presentation transcript:

Process Analytical Technology: An Industry Perspective John G. Shabushnig, Ph.D. Pharmacia Corporation February 25, 2002

Vision From … Laboratory based, finished product testing To … On-Line, in-process testing

Why use it?  Improved process control  Reduced testing cost  Reduced cycle time  Reduced in-process inventory

What is it?  Spectroscopic Near IR LIF  Physical Viscosity Specific Gravity  Optical Refractive Index  Electrical Impedance, Resistance Dielectric Constant Specific Ion (pH, etc.) Temperature Pressure

Common Attributes  Non-destructive  Limited/No sample prep  Convenient process interface Fiber optics Multipoint measurement  Rapid response time  Adequate dynamic range

Familiar Applications  Moisture Lyophilized Powders Granulations Compressed Tablets  Potency Sterile Aqueous Suspensions Blend uniformity  Identification Raw Materials Packaging Materials Finished Product  Sterilization Process Steam VHP

How used?  Support process development Reduced laboratory testing  Parallel testing Rapid confirmation of process performance Laboratory assay used for lot release “Don’t ask, don’t tell”  Lot release Limited implementation

Where are we now?  Phase II?  Demonstrated efficacy  Good science  Incomplete engineering/development

Obstacles to broader use  Catch 22 Ideally, methods developed during product development –Risk delay of product approval Duplicate method development cost if implemented after approval –Supplement required to implement  Regulatory acceptance  Complexity, Reliability Limited option for retest

Where do we go from here?  Improve measurement equipment More rugged and reliable Smaller, faster, cheaper  Improve regulatory climate Reduce uncertainty Support PAT option  Identify high-value, high-success applications to model  Develop guidelines for development and validation

Acknowledgements  LE Fox  RM Leasure  JG White  RG Whitfield  SJ Doherty